- Home
- IPHA vs MYPS Comparison
IPHA vs MYPS Comparison
Compare IPHA & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- MYPS
- Stock Information
- Founded
- IPHA 1999
- MYPS 2011
- Country
- IPHA France
- MYPS United States
- Employees
- IPHA N/A
- MYPS N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- IPHA Health Care
- MYPS Technology
- Exchange
- IPHA Nasdaq
- MYPS Nasdaq
- Market Cap
- IPHA 160.1M
- MYPS 129.1M
- IPO Year
- IPHA 2019
- MYPS N/A
- Fundamental
- Price
- IPHA $2.16
- MYPS $0.97
- Analyst Decision
- IPHA Strong Buy
- MYPS Buy
- Analyst Count
- IPHA 1
- MYPS 5
- Target Price
- IPHA $11.00
- MYPS $2.50
- AVG Volume (30 Days)
- IPHA 6.4K
- MYPS 259.1K
- Earning Date
- IPHA 09-17-2025
- MYPS 08-04-2025
- Dividend Yield
- IPHA N/A
- MYPS N/A
- EPS Growth
- IPHA N/A
- MYPS N/A
- EPS
- IPHA N/A
- MYPS N/A
- Revenue
- IPHA $20,831,349.00
- MYPS $261,058,000.00
- Revenue This Year
- IPHA $350.96
- MYPS N/A
- Revenue Next Year
- IPHA $32.92
- MYPS N/A
- P/E Ratio
- IPHA N/A
- MYPS N/A
- Revenue Growth
- IPHA N/A
- MYPS N/A
- 52 Week Low
- IPHA $1.29
- MYPS $0.90
- 52 Week High
- IPHA $3.51
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- IPHA 52.85
- MYPS 37.44
- Support Level
- IPHA $2.04
- MYPS $0.95
- Resistance Level
- IPHA $2.20
- MYPS $1.06
- Average True Range (ATR)
- IPHA 0.10
- MYPS 0.05
- MACD
- IPHA -0.02
- MYPS 0.01
- Stochastic Oscillator
- IPHA 33.83
- MYPS 38.28
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.